Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Search
Home
Emerging Therapy
Page 23
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Aquestive Works with FDA to Resolve Hurdles for its New Sublingual Epinephrine Candidate
Dave Bloom
-
2026/01/09
Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025
Very Low-Dose Multi-Nut OIT Promising for Children with Multiple Food Allergies
DBV to Submit FDA Application After Viaskin Peanut Patch Achieves Goals in Phase 3 Trial
Mabylon Begins Human Clinical Trials of New Peanut Allergy Treatment
Aimmune Therapeutics Presents New AR101 Data Including Demonstrated Reduction in Accidental...
News Wire ~ 3rd Party Press Release
-
2019/02/25
0
FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray
News Wire ~ 3rd Party Press Release
-
2019/02/19
0
Study: Treatment with Omalizumab Raises Tolerance in Patients with Severe Food...
Dave Bloom
-
2019/02/15
0
DBV to Resubmit Application to FDA for Viaskin Peanut Approval in...
News Wire ~ 3rd Party Press Release
-
2019/02/14
0
Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate
Dave Bloom
-
2019/01/16
0
Company Developing Microbiome-Derived Food Allergy Therapy Raises $27 Million
Dave Bloom
-
2018/12/28
0
Aimmune Submits FDA Application to Offer AR101 for the Treatment of...
News Wire ~ 3rd Party Press Release
-
2018/12/21
0
DBV Withdraws FDA Application for Viaskin Peanut with Plan to Resubmit
Dave Bloom
-
2018/12/21
0
Aimmune to Begin Phase 2 Trials of Egg Allergy OIT Candidate
News Wire ~ 3rd Party Press Release
-
2018/12/20
0
Study: Anti-IgE Shots During Pregnancy May Provide a Lifetime of Protection...
Dave Bloom
-
2018/12/17
0
1
...
22
23
24
...
31
Page 23 of 31